AstraZeneca · 1 day ago
Associate Director, Cell Therapy Territory Operations Manager
AstraZeneca's Cell Therapy division is focused on treating and curing complex diseases through innovative science. The Associate Director – Territory Operations Manager will lead strategic initiatives in cell therapy, ensuring compliance and operational excellence while building relationships with clinical and operational leaders.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead and support strategic initiatives across clinical and commercial cell therapy from development to post-market
Be a key leader within Internal AZ teams (Program Management, QA, Manufacturing, Supply Chain, Medical Affairs, Market Access, Compliance, Sales/Marketing)
Establish service lines with external partners (PIs, Physicians, Nursing, Apheresis, Cell Therapy Lab, other HCPs/leadership)
Serve as SME, driving decisions and projects at multi-country/local levels; influence strategy, governance, and cross-functional execution
Acts as the technical expert and authoritative source of knowledge in cell therapy workflows and brings expertise to site interactions
Build and maintain relationships with stakeholders at assigned Sites
Operate within regulatory/accreditation standards (e.g., FACT) ensuring compliance, audit readiness, and continuous improvement
Guide clinical workflows; ensure standards; advance apheresis excellence; optimize product handling; inform health outcomes
Act as primary operations readiness liaison; collaborate with Supply Chain to align logistics and site needs
Provide exemplary customer service while building business relations with clinical/operational leaders
Lead cross-functional meetings to develop product/patient workflows for trials and future commercial products
Maintain strong collaboration with Program Management, SMM, Supply Chain, Manufacturing, Quality, Medical, Commercial, Cell Therapy Hub, to manage customer centers and clinical care for the portfolio
Oversee operational/clinical aspects of raw material collection, product receipt/storage/distribution/infusion, and COI/COC
Design and deliver training to PIs, MD, Nursing Staff, Apheresis, and Cell Therapy Laboratory and Coordinator staff
Lead Site activation using risk-based tools for certification, training, and monitoring
Train Site HCPs on product needs; ensure COI/COC access for trained individuals with Cell Therapy Hub
Oversee Site logistics and manage regional account changes with Cell Therapy Hub
Respond to SOP deviations with expertise and collegiality
Support/own quality records (Deviations, CAPA, Change Control) with Cell Therapy Hub and QA
Travel up to 50%
Qualification
Required
Bachelor's degree (Nursing, Physician Assistant) with thorough knowledge/hands-on experience in Cell Therapy
8+ years' experience in cell therapy with progressive leadership
Expertise in service lines (infrastructure, resourcing, costs, quality metrics)
Proven delivery to timelines, cost, and quality; collaboration with internal/external providers
Excellent knowledge of cell therapy standards/regulations
Experience selecting/overseeing external providers and developing contracts
Preferred
Advanced scientific degree; broad understanding across patient operations, manufacturing interfaces, quality, regulatory, market access; project management experience
Program/Quality qualifications (e.g., PMP, CPHQ)
Experience across academic/Sponsor settings and countries
Early-phase delivery across product lifecycle and multiple therapeutic areas
Salesforce or similar CRM experience
Preference for candidate to be based in the Los Angeles, CA area
Benefits
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase